Stock Exchange of Thailand Dear Sir, With reference to the Minutes 11/2017 of the Company Directors’ meeting dated November 13, 2017, the Board resolved to approve the reviewed financial statements of
May 15, 2019 Subject : Management Discussion and Analysis for quarter ended March 31, 2019 Attention : President The Stock Exchange of Thailand 1. Operating Performance 1.1 Revenues Consolidated
30th June 2018 To : Managing Director Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at
May 15, 2020 Subject : Management Discussion and Analysis for 1st quarter ended March 31, 2020 Attention : President The Stock Exchange of Thailand 1. Operating Performance 1.1 Revenues Consolidated
-Translation- No. ECF2 041/2561 12 November 2018 Subject: Management Discussion and Analysis of the 3rd quarter ended September 30, 2018 To President The Stock Exchange of Thailand East Coast
Consolidated Financial Statements for the second quarter of 2020, reviewed by auditor, to the Stock Exchange of Thailand. The clarification on the Company’s operating results for the second quarter of 2020, are
May 9, 2018 Re : Operating Performance for Q1/2018 To : Director and Manager of the Stock Exchange of Thailand Revenue from sales and rendering of services L&E’s consolidated revenue from sales of
- Translation - Ref : LPH/SET 2018/014 May 11, 2018 Subject : Clarification on the Operating Results for the three-month period ended March 31, 2017 (Q1/2017) To : President The Stock Exchange of
February 20, 2019 Re: Management Discussion and Analysis for full year 2018 To: Director and Manager of the Stock Exchange of Thailand Revenue from sales and rendering of services L&E’s consolidated
February 18, 2020 Re: Management Discussion and Analysis for full year 2019 To: Director and Manager of the Stock Exchange of Thailand Revenue from sales and rendering of services L&E’s consolidated